Pharmacological study of rifampicin after repeated high dosage during intermittent combined therapy. II. Bilirubin levels and other biochemical determinations.
D000410:Alanine Transaminase / Q000097:blood; D000704:Analysis of Variance; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood*; D004338:Drug Combinations; D004977:Ethambutol / Q000008:administration & dosage / Q000494:pharmacology; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000494:pharmacology; D008099:Liver / Q000187:drug effects*; D008107:Liver Diseases / Q000503:physiopathology; D008111:Liver Function Tests; D012293:Rifampin / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D013997:Time Factors
D004338:Drug Combinations; D004977:Ethambutol; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001663:Bilirubin; D007538:Isoniazid; D012293:Rifampin